Cargando…

Correction: NLRP6 targeting suppresses gastric tumorigenesis via P14(ARF)–Mdm2–P53-dependent cellular senescence

Detalles Bibliográficos
Autores principales:	Wang, Haibin, Xu, Guoxing, Huang, Zhengjie, Li, Weizheng, Cai, Huali, Zhang, Yunda, Xiong, Disheng, Liu, Gang, Wang, Shengjie, Xue, Zengfu, Luo, Qi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2018
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6231455/ https://www.ncbi.nlm.nih.gov/pubmed/30464807 http://dx.doi.org/10.18632/oncotarget.26283

Ejemplares similares

LRP6 targeting suppresses gastric tumorigenesis via P14(ARF)–Mdm2–P53-dependent cellular senescence
por: Wang, Haibin, et al.
Publicado: (2017)

Pinning Control for the p53-Mdm2 Network Dynamics Regulated by p14ARF
por: Suarez, Oscar J., et al.
Publicado: (2020)

It’s Getting Complicated—A Fresh Look at p53-MDM2-ARF Triangle in Tumorigenesis and Cancer Therapy
por: Kung, Che-Pei, et al.
Publicado: (2022)

Overexpression of CCDC69 activates p14(ARF)/MDM2/p53 pathway and confers cisplatin sensitivity
por: Cui, Long, et al.
Publicado: (2019)

The RP-Mdm2-p53 Pathway and Tumorigenesis
por: Miliani de Marval, Paula L., et al.
Publicado: (2011)

Aberrant Expression of pRb, p16, p14ARF, MDM2, p21 and p53 in Squamous Cell Carcinomas of Lung
por: Xue, Qi, et al.
Publicado: (2001)

Overexpression of COUP-TFII suppresses proliferation and metastasis of human gastric cancer cells
por: Ding, Weiji, et al.
Publicado: (2018)

hCINAP alleviates senescence by regulating MDM2 via p14ARF and the HDAC1/CoREST complex
por: Huang, Xinping, et al.
Publicado: (2023)

Loss of p53 function at late stages of tumorigenesis confers ARF-dependent vulnerability to p53 reactivation therapy
por: Klimovich, Boris, et al.
Publicado: (2019)

MDM2-Mediated Degradation of p14ARF: A Novel Mechanism to Control ARF Levels in Cancer Cells
por: Vivo, Maria, et al.
Publicado: (2015)

Oxaliplatin-Induced Senescence in Colorectal Cancer Cells Depends on p14(ARF)-Mediated Sustained p53 Activation
por: Tomicic, Maja T., et al.
Publicado: (2021)

Genetic Variation in MDM2 and p14 (ARF) and Susceptibility to Salivary Gland Carcinoma
por: Jin, Lei, et al.
Publicado: (2012)

Decreased Mdm2 Expression Inhibits Tumor Development and Extends Survival Independent of Arf and Dependent on p53
por: Eischen, Christine M., et al.
Publicado: (2012)

Spliced MDM2 isoforms promote mutant p53 accumulation and gain-of-function in tumorigenesis
por: Zheng, Tongsen, et al.
Publicado: (2013)

The Senescence Markers p16INK4A, p14ARF/p19ARF, and p21 in Organ Development and Homeostasis
por: Wagner, Kay-Dietrich, et al.
Publicado: (2022)

HBP1-mediated Regulation of p21 Protein through the Mdm2/p53 and TCF4/EZH2 Pathways and Its Impact on Cell Senescence and Tumorigenesis
por: Chen, Yifan, et al.
Publicado: (2016)

Loss of miRNA biogenesis induces p19(Arf)-p53 signaling and senescence in primary cells
por: Mudhasani, Rajini, et al.
Publicado: (2008)

MicroRNA-339-5p inhibits colorectal tumorigenesis through regulation of the MDM2/p53 signaling
por: Zhang, Cen, et al.
Publicado: (2014)

The MDM2-p53 pathway revisited
por: Nag, Subhasree, et al.
Publicado: (2013)

Energetic Landscape of MDM2-p53 Interactions by Computational Mutagenesis of the MDM2-p53 Interaction
por: Thayer, Kelly M., et al.
Publicado: (2016)

MDM2 is an important prognostic and predictive factor for platin–pemetrexed therapy in malignant pleural mesotheliomas and deregulation of P14/ARF (encoded by CDKN2A) seems to contribute to an MDM2-driven inactivation of P53
por: Walter, R F H, et al.
Publicado: (2015)

The p53 Inhibitor MDM2 Facilitates Sonic Hedgehog-Mediated Tumorigenesis and Influences Cerebellar Foliation
por: Malek, Reem, et al.
Publicado: (2011)

Disruption of the RP-MDM2-p53 pathway accelerates APC loss-induced colorectal tumorigenesis
por: Liu, Shijie, et al.
Publicado: (2016)

The effects of fucodian on senescence are controlled by the p16(INK4a)-pRb and p14(Arf)-p53 pathways in hepatocellular carcinoma and hepatic cell lines
por: MIN, EUN-YOUNG, et al.
Publicado: (2014)

Cirrhotic livers reveal genetic changes in the MDM2-P14ARF system of cell cycle regulators
por: Schlott, T, et al.
Publicado: (2002)

microRNA-1827 represses MDM2 to positively regulate tumor suppressor p53 and suppress tumorigenesis
por: Zhang, Cen, et al.
Publicado: (2016)

Genetic Variants in the p14ARF/MDM2/TP53 Pathway Are Associated with the Prognosis of Esophageal Squamous Cell Carcinoma Patients Treated with Radical Resection
por: Li, Jing, et al.
Publicado: (2016)

CALB1 enhances the interaction between p53 and MDM2, and inhibits the senescence of ovarian cancer cells
por: Cao, Long-Qiao, et al.
Publicado: (2019)

PRL-3 promotes breast cancer progression by downregulating p14(ARF)-mediated p53 expression
por: Xie, Hua, et al.
Publicado: (2018)

Role of p14ARF-HDM2-p53 axis in SOX6-mediated tumor suppression
por: Wang, J, et al.
Publicado: (2016)

Detection of P53 and Mdm2 in vitiligo
por: Wiwanitkit, Viroj
Publicado: (2013)

Evolution of the p53-MDM2 pathway
por: Åberg, Emma, et al.
Publicado: (2017)

Acceleration of Gastric Tumorigenesis Through MKRN1-Mediated Posttranslational Regulation of p14ARF
por: Ko, Aram, et al.
Publicado: (2012)

Novel Allosteric Mechanism of Dual p53/MDM2 and p53/MDM4 Inhibition by a Small Molecule
por: Grinkevich, Vera V., et al.
Publicado: (2022)

Bivalent binding of p14ARF to MDM2 RING and acidic domains inhibits E3 ligase function
por: Kowalczyk, Dominika, et al.
Publicado: (2022)

Regulation of p53: a collaboration between Mdm2 and MdmX
por: Pei, Dongsheng, et al.
Publicado: (2012)

Regulation of kidney development by the Mdm2/Mdm4–p53 axis
por: El-Dahr, Samir, et al.
Publicado: (2017)

The Dual Interactions of p53 with MDM2 and p300: Implications for the Design of MDM2 Inhibitors
por: Kannan, Srinivasaraghavan, et al.
Publicado: (2019)

Poor prognosis and SATB1 overexpression in solid tumors: a meta-analysis
por: Wang, Shengjie, et al.
Publicado: (2018)

Reduced transcriptional activity in the p53 pathway of senescent cells revealed by the MDM2 antagonist nutlin-3
por: Huang, Baoying, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_l88rpba8kjj060ld1u3sfq99dl